Suspendilicious: unveiling the marvels of lipid suspensions
3/14/2018 11:20 - 11:55
Pre-clinical oral dosing of suspensions of solid dispersions
Pre-clinical oral dosing of suspensions of salts of very weak bases
Furthermore, the investigation of factors which influence the mass transfer kinetics from lipid suspensions to gastro-intestinal fluids will be discussed along with strategies to modulate the mass transfer kinetics.
Janssen Pharmaceutica (a division of Johnson & Johnson)
Dr. Kristof Kimpe obtained a master degree in chemistry at the university of Leuven in 1999 and received his Ph.D. in chemistry in 2003 at the same university. He joined Janssen Pharmaceutica in 2005 and assumed global, end-to-end responsibility for excipients. In 2016 Dr. Kimpe joined the preformulation group of the pharmaceutical sciences department, supporting drug product development all the way from pre-clinical to commercial formulations.